BioCryst Pharmaceuticals, Inc. Made Headway

Thu, May 06, 2021 at 05:30 PM
BioCryst Pharmaceuticals, Inc. Made Headway

BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ) rocketted at $12.92, a gain of 21%. On Wed, May 05, 2021, BCRX:NASDAQ hit a New 2-Week Low of $10.68. The stock got featured on our News Catalysts scanner on Thu, May 06, 2021 at 02:00 PM in the 'MISCELLANEOUS' category. From Wed, Apr 21, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days

The stock spiked on Mon, Mar 22, 2021 at $14.24 with a volume of 18M+, and its share price has been moving sideways in recent weeks.

About BioCryst Pharmaceuticals, Inc. (BCRX:NASDAQ)

Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.